Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Príomhchruthaitheoirí: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media
2019
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
de réir: Purvis, G, et al.
Foilsithe / Cruthaithe: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
de réir: Zhibin Yan, et al.
Foilsithe / Cruthaithe: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
de réir: John, C, et al.
Foilsithe / Cruthaithe: (2004) -
Annexin A1 in the brain--undiscovered roles?
de réir: Solito, E, et al.
Foilsithe / Cruthaithe: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
de réir: Buckingham, J, et al.
Foilsithe / Cruthaithe: (2006)